{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:40:39Z","timestamp":1762101639963},"reference-count":18,"publisher":"Akademiai Kiado Zrt.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Microbiology and Immunology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1556\/eujmi-d-14-00026","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T02:30:09Z","timestamp":1418783409000},"page":"198-203","source":"Crossref","is-referenced-by-count":10,"title":["<i>Pseudomonas<\/i>infection in antibody deficient patients"],"prefix":"10.1556","volume":"4","author":[{"given":"Sai","family":"Duraisingham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Grigoriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","volume-title":"UK Cystic Fibrosis registry 2012 Annual Data Report. Bromley, Kent","year":"2012"},{"key":"2","volume-title":"Cystic Fibrosis Foundation patient registry 2012 Annual Data Report. Bethesda, Maryland","author":"Foundation CF","year":"2012"},{"key":"3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li Z","year":"2005","journal-title":"JAMA"},{"key":"4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable noncystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia MA","year":"2007","journal-title":"Chest"},{"key":"5","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson CB","year":"1997","journal-title":"Eur Respir J"},{"key":"6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jcp.55.8.577","article-title":"Survey of infection in patients receiving antibody replacement treatment for immune deficiency","volume":"55","author":"Pettit SJ","year":"2002","journal-title":"J Clin Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein JA","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis","volume":"23","author":"Frederiksen B","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcf.2008.06.009","article-title":"Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience","volume":"7","author":"Hansen CR","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ppul.10401","article-title":"Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center","volume":"37","author":"Lee TW","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1569-1993(11)60011-8","article-title":"Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report","volume":"10","author":"Pressler T","year":"2011","journal-title":"J Cyst Fibros"},{"key":"12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ppul.20562","article-title":"Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"42","author":"Ratjen F","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee TW","year":"2003","journal-title":"J Cyst Fibros"},{"key":"14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.06.00100805","article-title":"Evaluating the \u201cLeeds criteria\u201d for Pseudomonas aeruginosa infection in a cystic fibrosis centre","volume":"27","author":"Proesmans M","year":"2006","journal-title":"Eur Respir J"},{"key":"15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcf.2008.08.002","article-title":"Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods","volume":"8","author":"Pressler T","year":"2009","journal-title":"J Cyst Fibros"},{"key":"16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/thx.53.9.732","article-title":"Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis","volume":"53","author":"Ballmann M","year":"1998","journal-title":"Thorax"},{"key":"17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring G","year":"2000","journal-title":"Eur Respir J"},{"key":"18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2249.2009.03954.x","article-title":"The European internet-based patient and research database for primary immunodeficiencies: results 2006\u20132008","volume":"157","author":"Gathmann B","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["European Journal of Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/eujmi-d-14-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:45:51Z","timestamp":1590140751000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/eujmi-d-14-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1556\/EUJMI-D-14-00026"],"URL":"https:\/\/doi.org\/10.1556\/eujmi-d-14-00026","relation":{},"ISSN":["2062-509X","2062-8633"],"issn-type":[{"value":"2062-509X","type":"print"},{"value":"2062-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}